mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
Clinical trial NCT07557602 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07557602
- Sponsor
- Vaccine Company, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-04
- Primary completion
- 2027-08-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.